Endotoxin tolerance after severe injury and its regulatory mechanisms

Journal of Trauma - Injury, Infection and Critical Care

Volumn 41, Issue 3, 1996, Pages 430-438

  Keel, Marius ^a   Schregenberger, Natina ^a   Steckholzer, Ursula ^a   Ungethüm, Udo ^a   Kenney, John ^b   Trentz, Otmar ^a   Ertel, Wolfgang ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Cytokine; Endotoxin tolerance; Trauma

Indexed keywords

CONCANAVALIN A; ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOREGULATION; INJURY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0029848463     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/00005373-199609000-00008     Document Type: Conference Paper

References (41)

1. Seatter SC, Li MH, Bubrick MP, et al: Endotoxin pretreatment of human monocytes alters subsequent endotoxin-triggered release of inflammatory mediators. Shock 3:252, 1995
2. Rodrick ML, Moss NM, Grbic JT, et al: Effects of in vivo endotoxin infusions on in vitro cellular immune responses in humans. J Clin Immunol 12:440, 1992
3. Granowitz EV, Porat R, Mier JW, et al: Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol 151:1637, 1993
4. Chen JD, Lapiere JC, Sauder DN, et al: Interleukin-1 alpha stimulates keratinocyte migration through an epidermal growth factor/transforming growth factor-alpha-independent pathway. J Invest Dermatol 104:729, 1995
5. Sori AJ, Rush BF Jr, Lysz TW, et al: The gut as source of sepsis after hemorrhagic shock. Am J Surg 155:187, 1988
6. Haskill S, Johnson C, Eierman D, et al: Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. J Immunol 140:1690, 1988
7. Castagna M, Takai Y, Kaibuchi K, et al: Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257:7847, 1982
8. Baker SP, O'Neill B, Haddon W, et al: The injury severity score: A method for describing patients with multiple injuries and evaluating emergency care. J Trauma 14:187, 1974
9. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 13:818, 1985
10. Van Deventer SJH, Buller HR, ten Cate JW, et al: Endotoxaemia: An early predictor of septicaemia in febrile patients. Lancet 1:605, 1988
11. Ertel W, Morrison MH, Ayala A, et al: Chloroquine attenuates hemorrhagic shock-induced suppression of Kupffer cell antigen presentation and major histocompatibility complex class II antigen expression through blockade of tumor necrosis factor and prostaglandin release. Blood 78:1781, 1991
12. Ertel W, Kremer JP, Kenney J, et al: Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341, 1995
13. Kenney JS, Masada MP, Eugui EM, et al: Monoclonal antibodies to human recombinant interleukin 1 (IL-1)β: Quantitation of IL-1β and inhibition of biological activity. J Immunol 138:4236, 1987
14. Ertel W, Jarrar D, Jochum M, et al: Enhanced release of elastase is not concomitant with increased secretion of granulocyte-activating cytokines in whole blood from patients with sepsis. Arch Surg 129:90, 1994
15. Arenzana Seisdedos F, Virelizier JL, Fiers W: Interferons as macrophage-activating factors. III. Preferential effects of interferon-γ on the interleukin 1 secretory potential of fresh or aged human monocytes. J Immunol 134:2444, 1985
16. Brunda MJ: Interleukin-12. J Leukoc Biol 55:280, 1994
17. Roumen RMH, Hendriks T, van der Ven-Jongekrijg J, et al: Cytokine patterns in patients after major vascular surgery, hemorrhage shock, and severe blunt trauma: Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 218:769, 1993
18. Damas P, Ledoux D, Nys M, et al: Cytokine serum level during severe sepsis in human: IL-6 as a marker of severity. Ann Surg 215:356, 1992
19. Abraham E, Raffin TA: Sepsis therapy trials: Continued disappointment or reason for hope? JAMA 271:1876, 1994
20. Fisher CJ Jr, Opal SM, Dhainaut JF, et al: Influence of an anti-TNF monoclonal antibody on cytokine levels in patients with sepsis: The CB0006 Sepsis Syndrome Study Group. Crit Care Med 21:318, 1993
21. Schinkel C, Zimmer S, Kremer JP, et al: Comparative analysis of transcription and protein release of the inflammatory cytokines interleukin-1 beta (IL-1β) and interleukin-8 (IL-8) following major burn and mechanical trauma. Shock 4:241, 1995
22. Hauser CJ, Lagoo S, Lagoo A, et al: Tumor necrosis factor α gene expression in human peritoneal macrophages is suppressed by extra-abdominal trauma. Arch Surg 130:1186, 1995
23. Cannon JG, Friedberg JS, Gelfand JA, et al: Circulating interleukin-1β and tumor necrosis factor-α concentrations after burn injury in humans. Crit Care Med 20:1414, 1992
24. Luger A, Graf H, Schwarz HP, et al: Decreased serum interleukin 1 activity and monocyte interleukin 1 production in patients with fatal sepsis. Crit Care Med 14:458, 1986
25. Reed LL, Martin M, Manglano R, et al: Bacterial translocation following abdominal trauma in humans. Circ Shock 42:1, 1994
26. Baron P, Traber LD, Traber DL, et al: Gut failure and translocation following burn and sepsis. J Surg Res 57:197, 1994
27. Rush BF, Sori AJ, Murphy TF, et al: Endotoxemia and bacteremia during hemorrhagic shock: The link between trauma and sepsis? Ann Surg 207:549, 1988
28. Faist E, Mewes A, Strasser T, et al: Alteration of monocyte function following major injury. Arch Surg 123:287, 1988
29. Fahmi H, Chaby R: Desensitization of macrophages to endotoxin effects is not correlated with a downregulation of lipopolysaccharide-binding sites. Cell Immunol 150:219, 1993
30. Berridge MJ: Inositol trisphosphate and diacylglycerol: Two interacting second messengers. Annu Rev Biochem 56:159, 1987
31. Sironi M, Bianchi M, Riganti F, et al: Suppression of interleukin-6 production in endotoxin tolerance in a mouse glioma cell line: Reversal by phorbol ester. Lymphokine Cytokine Res 12:39, 1993
32. Mengozzi M, Sironi M, Gadina M, et al: Reversal of defective IL-6 production in lipopolysaccharide-tolerant mice by phorbol myristate acetate. J Immunol 147:899, 1991
33. Romagnani S: Human TH1 and TH2 subsets: Doubt no more. Immunol Today 12:256, 1991
34. Livingston DH, Appel SH, Wellhausen SR, et al: Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg 123:1309, 1988
35. Chan SH, Perussia B, Gupta JW, et al: Induction of interferon γ production by natural killer cell stimulatory factor: Characterization of the responding cells and synergy with other inducers. J Exp Med 173:869, 1991
36. Haas JG, Meyer N, Riethmüller G, et al: Inhibition of lipopolysaccharide-induced in vitro desensitization by interferon-γ. Eur J Immunol 20:1181, 1990
37. Randow F, Syrbe U, Meisel C, et al: Mechanism of endotoxin desensitization: Involvement of interleukin-10 and transforming growth factor beta. J Exp Med 181:1887, 1995
38. Deitch EA: Multiple organ failure: Pathophysiology and potential future therapy. Ann Surg 216:117, 1992
39. Fan XD, Goldberg M, Bloom BR: Interferon-γ-induced transcriptional activation is mediated by protein kinase C. Proc Natl Acad Sci U S A 85:5122, 1988
40. Dries DJ, Jurkovich GJ, Maier RV, et al: Effect of interferon gamma on infection-related death in patients with severe injuries: A randomized, double-blind, placebo-controlled trial. Arch Surg 129:1031, 1994
41. Miles RH, Paxton TP, Dries DJ, et al: Interferon-gamma increases mortality following cecal ligation and puncture. J Trauma 36:607, 1994